Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 4 HIV Infections 4 Acquired Immunodeficiency Syndrome 4 Rectal Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Cancer Metastatic 1 Advanced Cancer 1

Interventions

Letrozole 3 Fulvestrant 3 exemestane 2 Trastuzumab 2 Irinotecan 2 Docetaxel 2 Capecitabine 2 Anastrozole 2 ribociclib 1 palbociclib 1 irinotecan sucrosofate 1 abemaciclib 1 Rogaratinib 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Liposomes 1 Everolimus 1 Cyclophosphamide 1 Cell Separation 1 Aromatase Inhibitors 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Cancer Metastatic × Liposomes × Clear all

NCT03328884 2025-04-23

Phenomenal

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡